GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » CM Life Sciences Inc (NAS:CMLFW) » Definitions » Land And Improvements

Switch to:

CMLFW (CM Life Sciences) Land And Improvements : $0.00 Mil (As of Dec. 2020)

View and export this data going back to 2020. Start your Free Trial

What is CM Life Sciences Land And Improvements?

CM Life Sciences's land and improvements for the quarter that ended in Dec. 2020 was $0.00 Mil.

CM Life Sciences Land And Improvements Historical Data

The historical data trend for CM Life Sciences's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CM Life Sciences Land And Improvements Chart

CM Life Sciences Annual Data

Trend

Dec20

Land And Improvements

-

CM Life Sciences Semi-Annual Data
	Jul20	Sep20	Dec20
Land And Improvements	-	-	-

CM Life Sciences Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

CM Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » CM Life Sciences Inc (NAS:CMLFW) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Corvex Management LP, 667 Madison Avenue, New York, NY, USA, 10065

Website

https://www.cmlifesciencesspac.com

CM Life Sciences Inc is a blank check company.

CM Life Sciences Headlines

From GuruFocus

CM Life Sciences, Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Closing of $442.75 Million Initial Public Offering

By Business Wire Business Wire • 09-04-2020

CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination

By Business Wire Business Wire • 07-02-2021

Sema4 to Participate in Upcoming Investor Conferences

By Business Wire Business Wire • 05-24-2021

CM LIFE SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CM Life Sciences - CMLF

By Business Wire Business Wire • 02-25-2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CM Life Sciences, Inc. - CMLF

By PRNewswire PRNewswire • 02-13-2021

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

By Business Wire Business Wire • 02-10-2021

NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

By Business Wire Business Wire • 04-19-2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CM Life Sciences, Inc. Merger

By Marketwired Marketwired • 02-12-2021

Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

By Business Wire Business Wire • 06-17-2021

CM Life Sciences, Inc. Announces Separate Trading of its Shares of Class A Common Stock and Warrants, on or about October 26, 2020

By Business Wire Business Wire • 10-24-2020

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.